Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of oligohydramnios with sildenafil citrate versus fluid therapy
PACTR201411000920150Recruiting
- Sponsor
- Menoufia University Hospitals
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sildenafil in Oligohydramnios (Oligo), sponsored by Menoufia University Hospitals. Primary endpoint: Change in amniotic fluid index. Started Nov 2014; status: recruiting.
02
Drugs
sildenafil
03
Conditions
Oligohydramnios (Oligo)
Beyond the preview
Go deeper on PACTR201411000920150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201411000920150.